OSMOTICA COSTA RICA SA has a total of 16 patent applications. Its first patent ever was published in 2001. It filed its patents most often in WIPO (World Intellectual Property Organization), Australia and Canada. Its main competitors in its focus markets pharmaceuticals are LIFE WELL LIVED LLC, N C PHARM LTD and EMPROS PHARMA AB.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 10 | |
#2 | Australia | 2 | |
#3 | Canada | 2 | |
#4 | EPO (European Patent Office) | 1 | |
#5 | United States | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds |
# | Name | Total Patents |
---|---|---|
#1 | Faour Joaquina | 13 |
#2 | Vergez Juan A | 12 |
#3 | Ricci Marcelo A | 10 |
#4 | Pastini Ana C | 6 |
#5 | Meyer Glenn A | 4 |
#6 | Feleder Ethel C | 3 |
#7 | Befumo Marcelo F | 3 |
#8 | Coppari Marcelo A | 2 |
#9 | Fischbein Gustavo A | 2 |
#10 | Krasuk Silvia | 2 |
Publication | Filing date | Title |
---|---|---|
WO2009000216A2 | A rupturing controlled release device comprising a subcoat | |
WO2007073702A2 | Multi-layered tablet with triple release combination | |
US2007275060A1 | Extended release solid pharmaceutical composition containing carbidopa and levodopa | |
WO2006089493A1 | Multilayer tablet comprising separating layers | |
WO2004087095A2 | Osmotic controlled release device containing zafirlukast and an h1-antagonist | |
EP1595535A2 | Delivery device containing venlafaxine and memantine and use method thereof | |
WO02053147A1 | Pharmaceutical composition for the treatment of cerebrovascular cognitive disease |